Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy, and advances in treatment have significantly improved survival. However, the intensified chemotherapeutic regimens, ...

Survival rates for childhood leukemia are improving thanks to new treatments. Acute lymphoblastic leukemia has the highest survival among all pediatric cancers, 80-85 percent. Seattle Children’s ...

Infantile ALL occurs in children under age one. It’s a rare and aggressive leukemia that typically has a poor outlook. Treatment involves chemo and sometimes a stem cell transplant. Leukemia refers to ...

Children born by planned C-section have an increased risk of developing acute lymphoblastic leukemia (ALL) later in life. This is shown by a study conducted by researchers at Karolinska Institutet.

Acute lymphoblastic leukemia (ALL) is known as a pediatric leukemia, with approximately half of cases occurring in children. ALL is the most common childhood malignancy, representing 75% to 80% of ...

Acute lymphocytic leukemia is one of the most commonly diagnosed cancers in children, although it is rare. It begins in the bone marrow and rapidly progresses. Long-term survival rates exceed 90%, but ...

Early exposure to PFAS, a group of widely used compounds known as "forever chemicals," was associated with a higher risk of acute lymphoblastic leukemia, the most common childhood cancer, according to ...

Researchers announced a significant paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia (T-ALL), an aggressive and high-risk form of cancer, to one frequently driven by ...

The FDA approved Blincyto for patients aged one month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia. The Food and Drug Administration ...

Scientists from St. Jude Children's Research Hospital, Seattle Children's and the Children's Oncology Group (COG) have identified novel genetic variations that influence relapse risk in children with ...